{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T13:08:38Z","timestamp":1791464918647,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:00:00Z","timestamp":1737158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ital J Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-N-methyl-D-aspartic receptor encephalitis (Anti-NMDAR encephalitis) is the most prevalent form of autoimmune encephalitis in pediatric patients. Autonomic dysfunction is a frequent symptom of Anti-NMDAR encephalitis, yet it often goes unnoticed by pediatricians. Studies have indicated that pediatric patients with autonomic dysfunction exhibit a poorer prognosis compared to those without. To date, research on autonomic dysfunction in encephalitis has predominantly focused on adults, with no studies conducted on pediatric populations. This analysis examines the clinical features of pediatric patients with Anti-NMDAR encephalitis complicated by autonomic dysfunction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective analysis of patients diagnosed with Anti-NMDAR encephalitis at the Department of Neurology, Children\u2019s Hospital affiliated to the\u00a0Capital Institute of Pediatrics, from June 2017 to June 2023. Patients were categorized based on the presence or absence of autonomic dysfunction during their illness. We summarized and compared the clinical features of children with autonomic dysfunction and analyzed the risk factors for its development in pediatric Anti-NMDAR encephalitis patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 56 children were included in this study. Twenty-two (39.3%) exhibited autonomic nervous dysfunction. The most prevalent symptom of autonomic dysfunction was cardiovascular autonomic dysfunction(21\/22, 95%),with the specific manifestations being sinus tachycardia (8 cases), ventricular premature beats (2 cases), atrioventricular block (2 cases), atrial premature beats (3 cases), and sinus bradycardia (4 cases),hypertension(1 case) and cardiac arrest(1 case). Other symptoms included gland secretion dysfunction (19\/22, 86%),ventilate dysfunction(3\/22,14%), thermoregulatory dysfunction (3\/22,14%), bladder dysfunction(2\/22,9%). Compared to the group without autonomic dysfunction, the group with dysfunction showed significantly higher rates of prodrome infection, tumor complications (all ovarian teratoma), consciousness disturbance, elevated cerebrospinal fluid protein, initiation of second-line and long-term immunotherapy, length of hospital stay, and hospitalization costs (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.05).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Among pediatric patients with Anti-NMDAR encephalitis, cardiovascular autonomic dysfunction is the most common form of autonomic dysfunction. Those with autonomic dysfunction have a worse prognosis and longer hospital stays. Active initiation of second-line and long-term immunotherapy is recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13052-025-01857-4","type":"journal-article","created":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:08:21Z","timestamp":1737158901000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Clinical features of autonomic dysfunction in children with anti-N-methyl-D aspartic receptor encephalitis"],"prefix":"10.1186","volume":"51","author":[{"given":"Dongqing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guannan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,18]]},"reference":[{"key":"1857_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577753","author":"H Ren","year":"2021","unstructured":"Ren H, Fan S, Zhao Y, Guan H. The changing spectrum of antibody-mediated encephalitis in China. Neuroimmunol. 2021. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577753.","journal-title":"Neuroimmunol"},{"key":"1857_CR2","doi-asserted-by":"publisher","unstructured":"Varley JA, Webb AJS, Balint B, et al. The movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic:an expert video-rating study. J Neurology. 2019. https:\/\/doi.org\/10.1136\/jnnp-2018-318584.","DOI":"10.1136\/jnnp-2018-318584"},{"key":"1857_CR3","doi-asserted-by":"publisher","unstructured":"Hu CC, Pan XL, Zhang MX, Chen HF. Paroxysmal speech disorder as the initial symptom in a young adult with anti-N-methyl-D-aspartate receptor encephalitis: A case report.\u00a0World J Clin Cases. 2022. https:\/\/doi.org\/10.12998\/wjcc.v10.i24.8648.","DOI":"10.12998\/wjcc.v10.i24.8648"},{"key":"1857_CR4","doi-asserted-by":"publisher","DOI":"10.1017\/cjn.2017.280","author":"J H\u00e9bert","year":"2018","unstructured":"H\u00e9bert J, El-Sadi F, Maurice C, Wennberg RA, Tang-Wai DF. Adult-Onset Anti-N-methyl-D-aspartate-receptor Encephalitis Presenting as a Non-Fluent Aphasia. Can J Neurol Sci. 2018. https:\/\/doi.org\/10.1017\/cjn.2017.280.","journal-title":"Can J Neurol Sci"},{"key":"1857_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00401-9","author":"F Graus","year":"2016","unstructured":"Graus F, Titulaer MJ, Balu R, et al. A clinical approach to diagnosis of autoimmune encephalitis. Lancet Neurol. 2016. https:\/\/doi.org\/10.1016\/S1474-4422(15)00401-9.","journal-title":"Lancet Neurol"},{"key":"1857_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-015-8002-2","author":"L Baysal-Kirac","year":"2016","unstructured":"Baysal-Kirac L, Tuzun E, Erdag E, et al. Neuronal autoantibodies in epilepsy patients with peri-ictal autonomic findings. J Neurol. 2016. https:\/\/doi.org\/10.1007\/s00415-015-8002-2.","journal-title":"J Neurol"},{"key":"1857_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2007.11.008","author":"E von Elm","year":"2008","unstructured":"von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008. https:\/\/doi.org\/10.1016\/j.jclinepi.2007.11.008.","journal-title":"J Clin Epidemiol"},{"key":"1857_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.609750","author":"L Yan","year":"2021","unstructured":"Yan L, Zhang S, Huang X, Tang Y, Wu J. Clinical Study of Autonomic Dysfunction in Patients With Anti-NMDA Receptor Encephalitis. Front Neurol. 2021. https:\/\/doi.org\/10.3389\/fneur.2021.609750.","journal-title":"Front Neurol"},{"key":"1857_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70310-1","author":"MJ Titulaer","year":"2013","unstructured":"Titulaer MJ, McCracken L, Gabilondo I, et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis:an observational cohort study. Lancet Neurol. 2013. https:\/\/doi.org\/10.1016\/S1474-4422(12)70310-1.","journal-title":"Lancet Neurol"},{"key":"1857_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2015.08.002","author":"JI Byun","year":"2015","unstructured":"Byun JI, Lee ST, Moon J, et al. Cardiac sympathetic dysfunction in anti-NMDA receptor encephalitis. Auton Neurosci. 2015. https:\/\/doi.org\/10.1016\/j.autneu.2015.08.002.","journal-title":"Auton Neurosci"},{"key":"1857_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(08)70224-2","author":"J Dalmau","year":"2008","unstructured":"Dalmau J, Gleichman AJ, Hughes EG, et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol. 2008. https:\/\/doi.org\/10.1016\/S1474-4422(08)70224-2.","journal-title":"Lancet Neurol"},{"key":"1857_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.858450","author":"Z Chen","year":"2022","unstructured":"Chen Z, Zhang Y, Wu X, Huang H, Chen W, Su Y. Characteristics and Outcomes of Paroxysmal Sympathetic Hyperactivity in Anti-NMDAR Encephalitis. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.858450.","journal-title":"Front Immunol"},{"key":"1857_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocn.2011.03.024","author":"M Lee","year":"2011","unstructured":"Lee M, Lawn N, Prentice D, Chan J. Anti-NMDA receptor encephalitis associated with ictal asystole. J Clin Neurosci. 2011. https:\/\/doi.org\/10.1016\/j.jocn.2011.03.024.","journal-title":"J Clin Neurosci"},{"key":"1857_CR14","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/eus014","author":"TM Nazif","year":"2012","unstructured":"Nazif TM, V\u00e1zquez J, Honig LS, Dizon JM. Anti-N-methyl-D-aspartate receptor encephalitis: an emerging cause of centrally mediated sinus node dysfunction. Europace. 2012. https:\/\/doi.org\/10.1093\/europace\/eus014.","journal-title":"Europace"},{"key":"1857_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2008.10.059","author":"T Kawabe","year":"2009","unstructured":"Kawabe T, Chitravanshi VC, Nakamura T, Kawabe K, Sapru HN. Mechanism of heart rate responses elicited by chemical stimulation of the hypothalamic paraventricular nucleus in the rat. Brain Res. 2009. https:\/\/doi.org\/10.1016\/j.brainres.2008.10.059.","journal-title":"Brain Res"},{"key":"1857_CR16","doi-asserted-by":"publisher","unstructured":"Wang GL, Yin F, Wang Y, et al.\u00a0Zhonghua Er Ke Za Zhi. 2019.\u00a0https:\/\/doi.org\/10.3760\/cma.j.issn.0578-1310.2019.02.012.","DOI":"10.3760\/cma.j.issn.0578-1310.2019.02.012"},{"key":"1857_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21756","author":"NR Florance","year":"2009","unstructured":"Florance NR, Davis RL, Lam C, et al. Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol. 2009. https:\/\/doi.org\/10.1002\/ana.21756.","journal-title":"Ann Neurol"},{"key":"1857_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2017.09.005","author":"Y Wang","year":"2017","unstructured":"Wang Y, Zhang W, Yin J, et al. Anti-N-methyl-d-aspartate receptor encephalitis in children of Central South China: Clinical features, treatment, influencing factors, and outcomes. J Neuroimmunol. 2017. https:\/\/doi.org\/10.1016\/j.jneuroim.2017.09.005.","journal-title":"J Neuroimmunol"},{"key":"1857_CR19","doi-asserted-by":"publisher","DOI":"10.1080\/01616412.2021.2000824","author":"X Dou","year":"2022","unstructured":"Dou X, Li D, Wu F, et al. The clinical features, treatment and outcomes of 33 children from Northwestern China with Anti-N-methyl-D-aspartate receptor encephalitis. Neurol Res. 2022. https:\/\/doi.org\/10.1080\/01616412.2021.2000824.","journal-title":"Neurol Res"},{"key":"1857_CR20","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.2095-428X.2019.24.002","author":"XJ Li","year":"2019","unstructured":"Li XJ. Clinical features of autoimmune encephalitis in children. Chinese Journal of Practical Pediatrics Clinical. 2019. https:\/\/doi.org\/10.3760\/cma.j.issn.2095-428X.2019.24.002.","journal-title":"Chinese Journal of Practical Pediatrics Clinical"},{"key":"1857_CR21","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201603-0507OC","author":"E de Montmollin","year":"2017","unstructured":"de Montmollin E, Demeret S, Brul\u00e9 N, et al. Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care. Am J Respir Crit Care Med. 2017. https:\/\/doi.org\/10.1164\/rccm.201603-0507OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"1857_CR22","doi-asserted-by":"publisher","DOI":"10.1212\/CON.0000000000000817","author":"EE Benarroch","year":"2020","unstructured":"Benarroch EE. Physiology and Pathophysiology of the Autonomic Nervous System. Continuum (Minneap Minn). 2020. https:\/\/doi.org\/10.1212\/CON.0000000000000817.","journal-title":"Continuum (Minneap Minn)"},{"key":"1857_CR23","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/B978-0-444-64032-1.00027-8","volume":"160","author":"CH Gibbons","year":"2019","unstructured":"Gibbons CH. Basics of autonomic nervous system function. Handb Clin Neurol. 2019;160:407\u201318. https:\/\/doi.org\/10.1016\/B978-0-444-64032-1.00027-8.","journal-title":"Handb Clin Neurol"},{"key":"1857_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.10.009","author":"LA Sposato","year":"2020","unstructured":"Sposato LA, Hilz MJ, Aspberg S, et al. Post-Stroke Cardiovascular Complications and Neurogenic Cardiac Injury: JACC State-of-the-Art Review. J Am Coll Cardiol. 2020. https:\/\/doi.org\/10.1016\/j.jacc.2020.10.009.","journal-title":"J Am Coll Cardiol"},{"key":"1857_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2014.00440","author":"SJ McDougall","year":"2015","unstructured":"McDougall SJ, M\u00fcnzberg H, Derbenev AV, Zsombok A. Central control of autonomic functions in health and disease. Front Neurosci. 2015. https:\/\/doi.org\/10.3389\/fnins.2014.00440.","journal-title":"Front Neurosci"},{"key":"1857_CR26","doi-asserted-by":"publisher","DOI":"10.1152\/advan.00027.2016","author":"RA Dampney","year":"2016","unstructured":"Dampney RA. Central neural control of the cardiovascular system: current perspectives. Adv Physiol Educ. 2016. https:\/\/doi.org\/10.1152\/advan.00027.2016.","journal-title":"Adv Physiol Educ"},{"key":"1857_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.autneu.2017.01.001","author":"MAP Fontes","year":"2017","unstructured":"Fontes MAP, Filho ML, Santos Machado NL, et al. Asymmetric sympathetic output: The dorsomedial hypothalamus as a potential link between emotional stress and cardiac arrhythmias. Auton Neurosci. 2017. https:\/\/doi.org\/10.1016\/j.autneu.2017.01.001.","journal-title":"Auton Neurosci"},{"key":"1857_CR28","doi-asserted-by":"publisher","unstructured":"Kawabe T, Chitravanshi VC, Kawabe K, Sapru HN. Cardiovascular function of a glutamatergic projection from the hypothalamic paraventricular nucleus to the nucleus tractus solitarius in the rat. Neuroscience. 2008. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.02.076.","DOI":"10.1016\/j.neuroscience.2008.02.076"},{"key":"1857_CR29","doi-asserted-by":"publisher","unstructured":"Krystal JH, Karper LP, Seibyl JP, et al. Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses.\u00a0Arch Gen Psychiatry. 1994. https:\/\/doi.org\/10.1001\/archpsyc.1994.03950030035004.","DOI":"10.1001\/archpsyc.1994.03950030035004"},{"key":"1857_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2020.577399","author":"M Yamakawa","year":"2020","unstructured":"Yamakawa M, Mukaino A, Kimura A, et al. Antibodies to the \u03b13 subunit of the ganglionic-type nicotinic acetylcholine receptors in patients with autoimmune encephalitis. J Neuroimmunol. 2020. https:\/\/doi.org\/10.1016\/j.jneuroim.2020.577399.","journal-title":"J Neuroimmunol"},{"key":"1857_CR31","doi-asserted-by":"publisher","DOI":"10.1007\/s12028-018-0536-6","author":"Y Zhang","year":"2018","unstructured":"Zhang Y, Liu G, Jiang M, Chen W, He Y, Su Y. Clinical Characteristics and Prognosis of Severe Anti-N-methyl-D-aspartate Receptor Encephalitis Patients. Neurocrit Care. 2018. https:\/\/doi.org\/10.1007\/s12028-018-0536-6.","journal-title":"Neurocrit Care"}],"container-title":["Italian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01857-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13052-025-01857-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13052-025-01857-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T00:08:25Z","timestamp":1737158905000},"score":1,"resource":{"primary":{"URL":"https:\/\/ijponline.biomedcentral.com\/articles\/10.1186\/s13052-025-01857-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,18]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1186\/s13052-025-01857-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4628973\/v1","asserted-by":"object"}]},"ISSN":["1824-7288"],"issn-type":[{"value":"1824-7288","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,18]]},"assertion":[{"value":"1 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. This study received approval from the Ethics Committee of the Capital Institute of Pediatrics (Ethics number: SHERLLM2024017), which exempted guardians from providing informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5"}}